Announced
Completed
ICON completed the acquisition of KCR for €80m.
Synopsis
ICON, a global provider of drug development and commercialization services, completed the acquisition of KCR, a full-service Contract Research Organization (CRO) specializing in providing clinical development solutions for €80m.
Principals
Show Details & Financials
Did you work on this deal?
Showcase your expertise to over 3 million dealmakers and industry leaders on Datasite.
Claim DealAll rights reserved. Copyright © 2025 Datasite